Ledger.Open graph →
SEC Form D · Amendment · filed November 12, 2020

BCD Bioscience, Inc

Offering
$4.8M
Sold
$4.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DAVIS, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Steven Watkins · Davis, CAExec · Director · PromoterCarlito Lebrilla · Davis, CADirector · PromoterStephen A. Arnall · Charlotte, NCExec · Director · PromoterMarkham H. Broyhill · Charlotte, NCDirector · PromoterMcdaniel D. Luther · Ringgold, GAExec · Director · PromoterDevendra Seebaluck · Lewes, DEDirector · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗